Abstract. To determine whether glucocorticoids affect the function of the bovine corpus luteum (CL) during the estrous cycle and early pregnancy, we examined the effects of exogenous cortisol or reduced endogenous cortisol on the secretion of progesterone (P4) and on pregnancy rate. In preliminary experiments, doses of cortisol and metyrapone (an inhibitor of cortisol synthesis) were established (n=33). Cortisol in effective doses of 10 mg blocked tumor necrosis factor-induced prostaglandin F 2α secretion as measured by its metabolite (PGFM) concentrations in the blood. Metyrapone in effective doses of 500 mg increased the P4 concentration. Thus, both reagents were then intravaginally applied in the chosen doses daily from Day 15 to 18 after estrus (Day 0) in noninseminated heifers (n=18) or after artificial insemination (n=36). Pregnancy was confirmed by transrectal ultrasonography between Days 28-30 after insemination. Plasma concentrations of P4 were lower in cortisol-treated heifers than in control heifers on Days 17 and 18 of the estrous cycle (P<0.05). However, the interestrus intervals were not different between control and cortisol-treated animals (P>0.05). Moreover, metyrapone increased P4 and prolonged the CL lifespan in comparison to control animals (P<0.05). Interestingly, in inseminated heifers, cortisol increased the pregnancy rate (75%) compared with control animals (58%), whereas metyrapone reduced the pregnancy rate to 16.7% (P<0.05). The overall results suggest that cortisol, depending on the physiological status of heifers (pregnant vs. nonpregnant), modulates CL function by influencing P4 secretion. Cortisol may have a positive influence on CL function during early pregnancy, leading to support of embryo implantation and resulting in higher rates of pregnancy in heifers. Key words: Cattle, Cortisol, Early pregnancy, Estrous cycle, Progesterone (J. Reprod. Dev. 58: [223][224][225][226][227][228][229][230] 2012) G lucocorticoids (GCs) are involved in many physiological processes [1, 2] , including female reproductive functions [3] in rabbits [4] , ewes [5] and humans [6] . Cortisol, an active GC, is an anti-inflammatory agent that acts to modulate the production and action of cytokines and prostaglandins required for ovulation, luteolysis, embryo implantation, fetal growth and placental development [3, 7] . It is synthesized from cholesterol in the adrenal cortex and is locally regulated by 11β-hydroxysteroid dehydrogenases (11β-HSDs) [8] . The biological action of GCs is mediated through the activation of intracellular GR receptors (GC-R). Two isoforms of GC-R, GC-Rα and GC-Rβ, have been identified [9, 10] . Access of GCs to GC receptors in target tissues is regulated by two 11β-HSDs, bidirectional 11β-HSD type 1 (11β-HSD1) that mainly converts cortisone to active cortisol [11] and 11β-HSD type 2 (11β-HSD2) that inactivates cortisol to cortisone [12] . Although both 11β-HSDs and GC receptors are expressed in the bovine corpus luteum (CL) [13, 14] and endometrium [8] throughout the estrous cycle and early pregnancy [15] , the role of GC in regulating CL function is still controversial.
G lucocorticoids (GCs) are involved in many physiological processes [1, 2] , including female reproductive functions [3] in rabbits [4] , ewes [5] and humans [6] . Cortisol, an active GC, is an anti-inflammatory agent that acts to modulate the production and action of cytokines and prostaglandins required for ovulation, luteolysis, embryo implantation, fetal growth and placental development [3, 7] . It is synthesized from cholesterol in the adrenal cortex and is locally regulated by 11β-hydroxysteroid dehydrogenases (11β-HSDs) [8] . The biological action of GCs is mediated through the activation of intracellular GR receptors (GC-R). Two isoforms of GC-R, GC-Rα and GC-Rβ, have been identified [9, 10] . Access of GCs to GC receptors in target tissues is regulated by two 11β-HSDs, bidirectional 11β-HSD type 1 (11β-HSD1) that mainly converts cortisone to active cortisol [11] and 11β-HSD type 2 (11β-HSD2) that inactivates cortisol to cortisone [12] . Although both 11β-HSDs and GC receptors are expressed in the bovine corpus luteum (CL) [13, 14] and endometrium [8] throughout the estrous cycle and early pregnancy [15] , the role of GC in regulating CL function is still controversial.
Our previous in vitro studies have suggested that cortisol suppresses tumor necrosis factor α (TNFα)-stimulated prostaglandin (PG) F 2α production in endometrial stromal cells [8] and inhibits apoptosis of cultured luteal cells induced by TNFα and interferon-γ (IFNG) [13] . Based on the results of in vitro studies, it seems that cortisol plays a role in preventing excessive uterine PGF 2α production and protecting the CL against apoptosis in nonpregnant cattle [13, 16] . In addition, a previous in vivo study in cattle has shown that repeated administrations of exogenous GCs during the luteal phase prolong luteal life span and the length of the estrous cycle [17] . Dexamethasone treatment in cattle extended luteal function due to delayed or impaired preovulatory follicular development [18] . Moreover, dexamethasone injection increased CL size but reduced systemic progesterone (P4) concentrations [19] . However, whether and how endogenous cortisol may affect bovine CL functions during the estrous cycle and early stages of pregnancy in vivo is poorly understood. Metyrapone, an inhibitor of cortisol biosynthesis, influences peripheral GC metabolism by regulating the reductase and dehydrogenase activity of 11β-HSD1 [20] . Previous studies have indicated that metyrapone not only blocks systemic cortisol production, but also decreases the local interconversion of cortisone to cortisol by directly inhibiting 11β-HSD in adrenal cells and hepatocytes [21] [22] [23] [24] [25] . Furthermore, the bovine endometrium [8, 26] and corpus luteum [13] have the capacity to convert cortisone to cortisol. Thus, metyrapone may be used to reduce the local availability of cortisol in the lumen of the reproductive tract and in the CL and to examine the effects of reduced levels of cortisol on the pregnancy rate and CL function in cattle.
Intravaginal administration is a widespread method of drug administration for antimicrobials, labor-inducing agents, prostaglandins and steroids [27, 28] . The vaginal mucosa has good absorption potential, and drugs administered via the vaginal route are easily, safely and effectively absorbed and distributed throughout the blood vessels of reproductive organs for a long period of time [29] . Recently, vaginal drug delivery has gained further interest due to investigations showing the existence of a uterine first-pass effect [30] . The above findings suggest that drugs administered through the vaginal route are transported to the uterus and achieve higher tissue concentrations than if administered orally or via intramuscular injection [31] . Thus, in our experiment in heifers, the intravaginal route was used to administer cortisol and metyrapone (11β-HSD1 inhibitor) dissolved in Vaseline gel to study their biological effects in this species.
To determine whether glucocorticoids affect pregnancy rate and corpus luteum function, we examined the effects of intravaginal applications of exogenous cortisol or reduced endogenous cortisol by intravaginal applications of 11β-HSD1 inhibitor (metyrapone) on pregnancy rate and on the secretion of P4 during the estrous cycle and early stage of pregnancy in heifers.
Materials and Methods
All animal procedures were approved by the Local Animal Care and Use Committee in Olsztyn, Poland (Agreement No. 06/2007/N).
Animals and surgical procedures
A total of 87 healthy Polish Holstein-Friesian heifers were used for experiments. The animals were made available for this study by their owners (Experimental Animal Farm of the Polish Academy of Sciences in Baranowo, and a private farm in Cieszymowo, Poland). After the study was finished, the heifers were returned to the owners as fully productive animals. Estrus in the heifers was synchronized using two injections of an analogue of PGF 2α (dinoprost, 5 mg, Dinolytic; Upjohn -Pharmacia N.V.S.A., Belgium) with an 11-day interval, as described and recommended in our previous study [32] . The development of ovarian follicles, changes in the size of the CL and uterine structure during the estrous cycle and early pregnancy were monitored daily by a veterinarian via per rectum ultrasonography examination (USG) and confirmed by observing the signs of estrus (i.e., vaginal mucus, standing behavior). The onset of estrus was taken as Day 0 of the estrous cycle. Only heifers with signs of estrus were chosen for the studies.
Determination of cortisol and metyrapone doses
Thirty-three heifers were used to choose the effective doses of cortisol and metyrapone. All applications were performed intravaginally on Day 15 of the estrous cycle via a catheter placed into the vagina lumen down to the orificium uteri externum, as described previously [33] . The heifers were infused with Vaseline gel (10 ml; control group; n=6), TNFα (n=3), four different doses of cortisol (Hydrocortisone, Sigma-Aldrich Chemie GmbH, Munich; Germany; No. H4001) dissolved in Vaseline gel (0.1, 0.5, 1 and 10 mg; cortisol group; n=12) followed by an intrauterine infusion of 10 ng of TNFα (recombinant human TNFα: rhTNF HF-13; kindly donated by Dainippon Sumitomo Pharma, Osaka, Japan) as previously shown [34] or four different doses of metyrapone dissolved in Vaseline gel (Metopirone TM , 11β-HSD inhibitor; 2-Methyl-1,2-di-3-pyridyl-1-propanone, Sigma-Aldrich Chemie GmbH, Munich, Germany; No. 856525; 1, 10, 100 and 500 mg; metyrapone group; n=12). The dose of TNFα and days of experiment were based on our previous data [34] . It has been previously shown in vivo that infusion of a low dose (10 ng) of TNFα into the uterus on Day 15 of the estrous cycle increased luteolytic PGF 2α output and induced luteolysis in cattle. Moreover, as shown by in vitro data, cortisol inhibited TNFα -stimulated PGF 2α secretion by cultured endometrial cells [8] . Thus, a dose of cortisol, which could be able to inhibit the stimulatory effect of 10 ng of TNFα on PGF 2α output in vivo, was tested to determine the effective dose of cortisol.
A polyvinyl catheter was inserted into the jugular vein on Day 14 of the estrous cycle for collection of blood samples as described previously [35] . The time of TNFα or metyrapone infusion was defined as 0 h. Blood samples were collected at -2, -1, 0, 0.5, 1, 2, 3 and 4 h and then at 2-h intervals until 12 h after infusions in the cortisol and metyrapone groups. For further examination of cortisol and metyrapone action during the estrous cycle and early pregnancy in heifers, the doses of 10 mg cortisol and 500 mg metyrapone were used. Plasma concentrations of P4, cortisol and 13,14-dihydro,15-keto-prostaglandin F 2α (PGFM) in plasma samples were measured.
Effects of cortisol and metyrapone applications between Days 15 and 18 of the estrous cycle
To demonstrate the possible influence of cortisol on the circulating concentration of P4 during the late luteal phase of the cycle, the first group of heifers (n=18) were infused intravaginally once a day with Vaseline gel (10 ml; control group; n= 6), cortisol dissolved in Vaseline gel (10 mg; n= 6) or metyrapone dissolved in Vaseline gel (500 mg; n= 6) from Day 15 to 18 of the estrous cycle, as described for the preliminary experiment. Blood samples were collected from the jugular vein on Days 0, 6, 12, 15, 16, 17, 18, 19 and 21 . Plasma concentrations of P4 in blood samples were measured.
Effects of cortisol and metyrapone applications between Days 15 and 18 after artificial insemination
To demonstrate the possible influence of cortisol on P4 secretion during early pregnancy and on pregnancy rate, the second group of heifers (n=36) were inseminated with semen from the same bull 60 and 72 h after the second PGF 2α injection. From Day 15 to 18 after insemination, heifers were infused intravaginally once a day with Vaseline gel (10 ml; control group; n=12), cortisol dissolved in Vaseline gel (10 mg; n=12) or metyrapone dissolved in Vaseline gel (Metopirone TM , 500 mg; n=12), as described for the preliminary experiment. Blood samples were collected on the following days after insemination: Days 0, 6, 12, 15, 16, 17, 18, 19 and 21. Pregnancy was confirmed by USG between Days 28-30. Plasma concentrations of P4 in blood samples were measured.
For P4 and PGFM determination, blood samples were collected into sterile 10-ml tubes containing 200 μl of stabilizer solution (0.3 M EDTA, 1% acid acetyl salicylic, pH 7.4). All tubes were immediately chilled on ice for 10 min and centrifuged at 2000 × g for 10 min at 4 C, and the obtained plasma was stored at -30 C until further analysis.
Progesterone determination
The concentrations of P4 in plasma samples were assayed using a direct enzyme immunoassay (EIA) according to the method described previously [36] . The P4 standard curve ranged from 0.39 to 25 ng/ml, and the effective dose for 50% inhibition (ED50) of the assay was 2.85 ng/ml. The intra-and interassay coefficients of variation averaged 6.6 and 8.4%, respectively.
13,14-dihydro,15-keto-prostaglandin F 2α (PGFM) determination
The concentrations of PGFM in the plasma samples were determined with a direct EIA according to the method described previously [36] . The PGFM standard curve ranged from 32.5 pg/ ml to 8000 pg/ml, and the ED50 of the assay was 315 pg/ml. The intra-and interassay coefficients of variation were on average 7.6 and 10.4%, respectively.
Cortisol determination
The concentrations of cortisol in the plasma were determined in duplicate after diethyl ether extraction by second antibody EIA using horseradish peroxidase enzyme-labelled cortisol as a tracer (1:80,000 final dilutions) and cortisol antibody (raised in a rabbit against cortisol-3-CMO; Cosmo Bio, Tokyo, Japan; 1:400,000 final dilutions), as described and characterized recently [34] . The standard curve ranged from 0.4 to 400 ng/ml, and the ED 50 of the assay was 1.68 ng/ml. The intra-and interassay CVs were on average 5.5 and 6.3%, respectively.
Statistical analysis
The analyses of P4, cortisol and PGFM in plasma samples collected from the jugular vein during all experiments were performed using a repeated measures design approach with treatments and time of sample collection (hours or days) being fixed effects with all interactions included (two-way ANOVA tests followed by the Bonferroni Multiple Comparison Test; GraphPad Prism Version 5.00, GraphPad Software, San Diego, CA, USA). P<0.05 was considered significant. Least adjusted means and standard errors were determined. The total amounts of P4 and PGFM released are shown by the area under the curve (relative units; Tables 1  and 2 ; means ± SEM) and were analyzed using one-way ANOVA followed by the Bonferroni Multiple Comparison Test (GraphPad Prism) as described previously [33] . The rate of pregnancy was analyzed using Chi-square (P<0.05).
Results

Determination of cortisol and metyrapone doses
Intravaginal application of cortisol on Day 15 of the estrous cycle did not significantly affect P4 levels as indicated by the analysis of area under the curve between 0 and 12 h post treatment (Table 1, Fig. 1a) . However, cortisol at a dose of 10 mg blocked the increase in PGFM induced by intrauterine infusion of TNFα (10 ng/animal; Table 1 , Fig. 1b) .
Intravaginal application of 500 mg of metyrapone on Day 15 of the estrous cycle induced an acute increase in circulating P4 levels starting 3 h after application (Table 2, Fig. 2a) . The levels of PGFM did not change significantly during the period of 12 h after metyrapone treatment ( Table 2 , Fig. 2b ).
There was no significant effect of intravaginal application of cortisol or metyrapone at any doses on the cortisol level in peripheral blood compared with that found in the control animals (data not shown).
Based on these results, the most effective doses of cortisol (10 mg) and metyrapone (500 mg) were chosen for the further studies to investigate the local effect of cortisol on the luteal function in the estrous cycle and early pregnancy.
Effects of cortisol and metyrapone applications between Days 15 and 18 of the estrous cycle on progesterone concentrations
Plasma concentrations of P4 were lower in cortisol-treated heifers than in the control heifers (only gel application) on Days 17 and 18 of the estrous cycle. However, the levels of circulating P4 did not decrease to less than 2 ng/ml until Day 19 (Fig. 3) . The interestrus intervals were not different between the control and cortisol treated groups (P<0.05). Moreover, metyrapone prolonged the functional life span of the CL as indicated by significantly greater levels of P4 compared with those in the control animals on Days 19 and 21 (P<0.05). In the heifers infused with 500 mg of metyrapone, spontaneous luteolysis was prevented, and the length of the estrous cycle was prolonged compared with that in the control group (over 30 days vs. 21.8 ± 0.77 days; P<0.05).
Effects of cortisol and metyrapone applications between Days 15 and 18 post-artificial insemination on pregnancy rate
The effects of cortisol and metyrapone on P4 secretion in pregnant and nonpregnant heifers is shown in Fig. 4 . Intravaginal application of metyrapone (500 mg, Fig. 4c ) prolonged the functional life span of the CL in nonpregnant heifers as indicated by the levels of P4 higher than 3 ng/ml until Day 21. However, in control (Fig. 4a) and cortisol (Fig. 4b) heifers, the levels of P4 were less 1 ng/ml on Day 21. The pregnancy rate of cortisol-treated heifers was higher than that of control heifers (75 vs. 58%), whereas the pregnancy rate of metyrapone-treated heifers was lower (P<0.05) than that of the control group (16.7% vs. 58%; Table 3 ).
Discussion
The results of the present study demonstrated that intravaginal application of exogenous cortisol from Day 15 to 18 post insemination increased the pregnancy rate, whereas inhibition of local cortisol biosynthesis by intravaginal application of metyrapone decreased the pregnancy rate in heifers. The same treatment with cortisol during the estrous cycle (in noninseminated heifers) decreased P4 between Days 17 and 18, but did not affect the time of complete luteolysis. On the other hand, treatment with metyrapone prolonged the life span of the CL, and luteolysis did not occur until Day 30 post ovulation. The above findings suggest that cortisol differently modulates the life span of the CL depending on physiological status of heifers (pregnant vs. nonpregnant).
We have previously shown that cortisol inhibits basal PGF 2α production in nonpregnant bovine endometrial stromal cells, whereas it does not affect PGF 2α production in epithelial cells in vitro [8] . This in vitro study suggests that cortisol could mainly act as an antiluteolytic factor suppressing PGF 2α production in the bovine endometrium. To examine whether cortisol modulates CL function in vivo, heifers were treated with cortisol around the time of the cycle when luteolysis normally begins (Days 15-18 of the estrous cycle). In the present study, the fact that cortisol did not affect the interestrus interval in cycling heifers but significantly increased the pregnancy rate in inseminated heifers suggests that depending on the type of endometrial cells (stromal and epithelial) and physiological status (pregnant versus nonpregnant), cortisol has different roles in regulating CL function. Our previous in vitro studies demonstrated that cortisol suppresses PGF 2α production in the endometrium [8] and suppresses apoptosis of luteal cells act- Values indicate the area under the curve (relative units, means ± SEM).
The area under the curve was analyzed using P4 and PGFM data between 0 and 12 h after intrauterine infusion with a luteolytic dose of TNFα (0 h). a-b Different superscript letters within a column indicate significant differences (P<0.05) among treated groups.
ing as a survival factor for bovine luteal cells [13] in cattle. Thus, cortisol may act to prevent luteolysis by decreasing luteolytic PGF 2α production and decreasing luteal cell death in cattle.
In ruminants, inhibition of the luteolytic mechanism to maintain the secretion of P4 is essential for the establishment of pregnancy. Interferon-tau (IFNT) has been identified as an embryonic signal responsible for the maternal recognition of pregnancy in ruminants [37] . During maternal recognition of pregnancy, the conceptus synthesizes and secretes IFNT with maximal production on Days 14-16 [38, 39] . It has been shown that the level of cortisol is locally regulated by IFNT in the ovine [40] and bovine [41] endometrium during pregnancy. Therefore, the different effects of exogenous cortisol or the inhibitor of cortisol biosynthesis in pregnant versus nonpregnant heifers observed in the present study may be due to the action of IFNT that is locally present at high concentrations in the uterine lumen of pregnant heifers but not in nonpregnant heifers. IFNT acts locally within the uterus to inhibit PGF 2α secretion [42] , and IFNT inhibits PGF 2α production but stimulates PGE 2 production by the uterus during early pregnancy [43, 44] . PGF 2α is a luteolytic factor [45] , whereas PGE 2 acts as a luteotrophic factor by stimulating P4 production [46] [47] [48] . In addition, poor embryo development is associated with low IFNT production, failed inhibition of luteolysis and embryo loss [49, 50] . These findings suggest that embryonic loss may occur because the embryos are unable to inhibit endometrial PGF 2α secretion. In the present study, Values indicate the area under the curve (relative units, means ± SEM).
The area under the curve was analyzed using P4 and PGFM data between 0 and 12 h after intravaginal infusion with metyrapone (0 h). a-b-c Different superscript letters within a column indicate significant differences (P<0.05) among treated groups.
intravaginal application of exogenous cortisol from Days 15 to 18 post insemination increased the pregnancy rate and reduced TNFα-stimulated PGFM levels, whereas the inhibition of local cortisol biosynthesis by intravaginal application of metyrapone decreased the pregnancy rate in heifers. These results agree with those of Boomsma et al. (2007) , who reported an increase in pregnancy rate as a result of GC administration [51] . The above results suggest that cortisol plays an important role in maintaining CL function by directly inhibiting uterine PGF 2α secretion to support embryo implantation and early embryonic development. In the present study, intravaginal applications of cortisol reduced P4 production compared with those of control heifers between Days 17 and 18 of the estrous cycle; however, the length of the cycle did not change compared with the control group. In contrast, reduced endogenous cortisol production by metyrapone application extended the length of the estrous cycle and increased P4 production. Glucocorticoids decreased the plasma P4 concentration in cattle [18, 52, 53] . Cortisol has the capacity to suppress luteal P4 secretion indirectly by inhibiting basal and luteinizing hormonereleasing hormone-induced release of luteinizing hormone from bovine pituitary cells [54] . At the end of the estrous cycle, cortisol can be involved in the luteolytic cascade by modulating uterine PGF 2α secretion and its action on the CL. PGF 2α released from the endometrium, especially the intercaruncular region of the surface epithelium of the uterus [55] , in a pulsatile manner causes regression of the bovine CL [56, 57] . Thus, for the initiation of bovine luteal regression, the pulsatile character of PGF 2α is much more important and plays a mandatory role rather than its absolute levels [56, 57] . Furthermore, cortisol has been suggested to act in reducing the high levels of uterine PGF and to be one of the factors responsible for the generation of PGF 2α pulses in vivo in cattle [58] . Cortisol is well-known as a local regulator/modulator of PG secretion [8] . Therefore, it can be suggested that cortisol is one of the most important components of the intrauterine regulatory system responsible for the autonomous, episodic PGF 2α output during luteolysis in cattle. Blockade of the endogenous cortisol production by metyrapone application may disturb the pulsatile PGF 2α output from the bovine uterus, consequently inhibiting luteolysis and prolonging the life span of the bovine CL. However, the effects and mechanisms of cortisol action on the autonomous, episodic PGF 2α output and/or on the frequency of PGF 2α pulses need to be determined in the future.
In conclusion, cortisol, depending on the physiological status of the heifers (pregnant vs. nonpregnant), modulates CL function by influencing P4 secretion. Cortisol may have a positive influence on CL function during early pregnancy, leading to support embryo implantation and resulting in higher rates of pregnancy in heifers.
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